Low Amyloid Burden Bodes Well for Future Dementia Risk

(MedPage Today) -- AMSTERDAM -- An offshoot of the closely watched A4 trial, which mainly tested whether the anti-amyloid drug solanezumab could delay onset of Alzheimer's disease in high-risk individuals, showed that older people with low initial...
Source: MedPage Today Neurology - Category: Neurology Source Type: news